Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Effects of Sivelestat Sodium on Improving ARDS in Patients With COVID-19

NCT06218862 is registered in ClinicalTrials.gov with The First Hospital of Jilin University as lead sponsor.

NCT NCT06218862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06218862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Effects of Sivelestat Sodium on Improving ARDS in Patients With COVID-19
Lead sponsor
The First Hospital of Jilin University
Phase
Observational
Overall status
Completed
Start date
December 1, 2022
Completion date
May 31, 2023
Enrollment
387 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ards due to disease caused by sars co-v-2